drugs

Showing 15 posts of 771 posts found.

brexit_flag_0

Brexit Health Alliance warns of UK at back of the medicine queue

January 29, 2018
Medical Communications, Sales and Marketing biotech, brexit, drugs, pharma, pharmaceutical

The Brexit Health Alliance (BHA) has cautioned that unless a favourable deal is struck, the UK could end Brexit negotiations …

Sanofi swoops for Ablynx in $4.8bn deal

January 29, 2018
Sales and Marketing Ablynx, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi has moved quickly to tie up a deal with Ablynx for $4.8 billion, when it looked more likely that …

pills_in_hand

NICE urges curbing the use of antibiotics for sore throats

January 26, 2018
Medical Communications Antibiotics, NICE, biotech, drugs, pharma, pharmaceutical

In a study published by the BMJ a few years ago, it was found that antibiotics were prescribed in 60% …

AZ’s triple therapy inhaler hits 8 out of 9 endpoints

January 26, 2018
Medical Communications, Research and Development AstraZeneca, COPD, biotech, drugs, pharma, pharmaceutical

AstraZeneca has made a brief announcement that its triple therapy inhaler manage to successfully hit eight of nine primary endpoints …

Biogen announces acquisition along with financials, but it’s tiny

January 26, 2018
Medical Communications, Sales and Marketing Biogen, Karyopharm, biotech, drugs, pharma, pharmaceutical

Biogen is one those companies, like Sanofi until its recent Bioverativ acquisition, that has real pressure to make a big …

aging_-_hand

Senescent cell findings provides Parkinson’s treatment clue

January 25, 2018
Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

Senescent cells are the dormant state that cells shift to in response to certain stressors, it is thought that they …

old_man_bar

Amyloid pathway doubts after latest Alzheimer’s failure

January 25, 2018
Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

There has been another drug failure in a large Phase 3 that once again crushes a hope for a possible …

gw_pharma

GW Pharma boasts new positive data, readying for approval

January 25, 2018
Research and Development GW Pharma, biotech, drugs, pharma, pharmaceutical

The latest data from GW Pharma is about as conclusively positive as you can usually hope to get with a …

celgene_exteriors-3

Celgene confirms rumours, with $9bn deal for Juno

January 22, 2018
Manufacturing and Production, Sales and Marketing CAR-T, Celgene, biotech, drugs, juno therapeutics, pharma, pharmaceutical

It seems like 2018 may well be the year for M&A that everyone had expected, as two major deals on …

biogen_austria_238

Biogen’s Spinraza to go before NICE

January 22, 2018
Sales and Marketing Biogen, Spinraza, biotech, drugs, pharma, pharmaceutical

Biogen received marketing approval from the European Commission for Spinraza (nusinersen), its treatment for spinal muscular atrophy (SMA), in May …

facilities_lg06

Court fines Dr Reddy’s for improperly packaging products

January 22, 2018
Sales and Marketing Dr Reddy's, biotech, drugs, pharma, pharmaceutical

On 18 December 2017, the District of New Jersey filed a complaint against Dr. Reddy’s Laboratories for failing to comply …

sanofi_new_paris_hq

Sanofi finally seals big deal with $11.6bn for Bioverativ

January 22, 2018
Sales and Marketing Sanofi, biotech, bioverativ, drugs, pharma, pharmaceutical

Sanofi interest in making a big acquisition has been clear for the last few years and its struggles to solidify …

sandoz

Novartis enters biosimilar agreement with Biocon

January 19, 2018
Medical Communications, Sales and Marketing Biocon, Novartis, Sandoz, biosimilars, biotech, drugs, pharma, pharmaceutical

Novartis’ Sandoz unit had already staked a claim to being one of the leaders in the developing biosimilar market and …

gilead-sciences

Gilead aims to claim edge with Pfizer CAR-T combo

January 18, 2018
Medical Communications, Research and Development Gilead, Kite, Yescarta, biotech, drugs, pharma, pharmaceutical

Although those in pharma often dislike any references to drugs competing with each other for market as in a ‘race’, …

sunrise-1756274_960_720

Riding the wave: The FDA and real world evidence

January 18, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, real world evidence

Following on from this week’s earlier piece on real world evidence, Jacqueline Corrigan-Curay, Director of CDER’s Office of Medical Policy at the FDA, …

The Gateway to Local Adoption Series

Latest content